Status:
COMPLETED
Immune and Recovery Modulating Impact of Probiotic Supplementation After Intense Resistance Exercise
Lead Sponsor:
Lindenwood University
Conditions:
Immune Markers
Complete Blood Count (CBC) With Platelet Differentials
Eligibility:
MALE
18-55 years
Phase:
NA
Brief Summary
This study proposal seeks to examine the efficacy of probiotic supplementation at mitigating changes in immune function and recovery after completion of intense, stressful exercise while also allowing...
Detailed Description
Study Visit 1 - Familiarization: During the familiarization visit, participants will first read and sign an IRB-approved informed consent document and complete a short form of the International Physi...
Eligibility Criteria
Inclusion
- Male
- Free from any disorders or diseases as stated on health history form
- Between the ages of 18 - 55 years of age
Exclusion
- Currently being treated for or are diagnosed with a cardiac, respiratory, circulatory, musculoskeletal, metabolic, obesity (defined as body mass index \> 30 kg/m2 and body fat greater than 30%), immune, autoimmune, hematological, neurological or endocrinological disorder or disease unless the scenario is viewed to not be a contraindication by the clinical coordinator of the study protocol. Individuals who are currently prescribed a hypertensive or cholesterol-lowering medication will be allowed entry into the study with clearance from clinical coordinator or their personal physician.
- Female
- An individual who is less than 18 and greater than 55 years of age will be excluded.
- Participants younger than 18 are excluded due to necessity of parental consent.
- Participants greater than 55 years old lie outside of the target demographic for the current study.
- Considered to be sedentary, defined as getting less than 30 minutes of moderate intensity physical activity for most days of the week.
- Currently not resistance training at least 2 days per week for the past 30 days
- Currently smoking or have quit smoking within the past 6 months
- Currently taking a probiotic. Individuals who currently report as taking a probiotic will be allowed entry into study protocol if a wash-out period of 30 days is observed.)
- Currently consuming any form of dietary supplements that are viewed by study investigators to confound the outcomes of the study protocol (i.e., creatine, beta-alanine, essential amino acids, beta-hydroxy-beta-methylbutyrate (HMB), branched-chain amino acids, or any pre-workout that contain combinations of these ingredients). Individuals who currently report as taking any of these supplements will be allowed entry into study protocol if a wash-out period of 30 days is observed.
Key Trial Info
Start Date :
April 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2021
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04441840
Start Date
April 16 2019
End Date
August 1 2021
Last Update
April 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lindenwood University
Saint Charles, Missouri, United States, 63301